These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22805801)

  • 1. Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance.
    Akter F; Amin MR; Osman KT; Anwar MN; Karim MM; Hossain MA
    World J Microbiol Biotechnol; 2012 Mar; 28(3):827-34. PubMed ID: 22805801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria.
    Alouache S; Estepa V; Messai Y; Ruiz E; Torres C; Bakour R
    Microb Drug Resist; 2014 Feb; 20(1):30-8. PubMed ID: 23952363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
    Morgan-Linnell SK; Becnel Boyd L; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):235-41. PubMed ID: 18838592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
    Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
    J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of fluoroquinolone resistant Escherichia coli from urban streams and municipal and hospital effluents.
    Varela AR; Macedo GN; Nunes OC; Manaia CM
    FEMS Microbiol Ecol; 2015 May; 91(5):. PubMed ID: 25764463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
    Guillard T; Cambau E; Chau F; Massias L; de Champs C; Fantin B
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5830-5. PubMed ID: 24018262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
    Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
    Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli.
    Fu Y; Zhang W; Wang H; Zhao S; Chen Y; Meng F; Zhang Y; Xu H; Chen X; Zhang F
    BMC Infect Dis; 2013 Jan; 13():8. PubMed ID: 23295059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
    Karczmarczyk M; Martins M; Quinn T; Leonard N; Fanning S
    Appl Environ Microbiol; 2011 Oct; 77(20):7113-20. PubMed ID: 21856834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Vinué L; Hooper DC; Jacoby GA
    Int J Antimicrob Agents; 2018 Mar; 51(3):479-483. PubMed ID: 29360506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing.
    Aoike N; Saga T; Sakata R; Yoshizumi A; Kimura S; Iwata M; Yoshizawa S; Sugasawa Y; Ishii Y; Yamaguchi K; Tateda K
    J Clin Microbiol; 2013 Jun; 51(6):1692-8. PubMed ID: 23515543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of ciprofloxacin-resistant extended-spectrum β-lactamase-producing enteric bacteria in hospital wastewater and clinical sources.
    Maheshwari M; Yaser NH; Naz S; Fatima M; Ahmad I
    J Glob Antimicrob Resist; 2016 Jun; 5():22-5. PubMed ID: 27436461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.